NSC |
Compound |
Enrichment |
Correlation |
NSC 745455 |
Null |
0.00770426557728506 |
0.22484997 |
NSC 748707 |
Null |
0.00770426557728506 |
0.015908058 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
0.00770426557728506 |
0.2295291 |
NSC 757113 |
METHOTREXATE(+/-) |
0.00770426557728506 |
0.39628438 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.00803384002766641 |
0.20333546 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00803384002766641 |
0.44099054 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.00803384002766641 |
0.45464648 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.00803384002766641 |
0.37328465 |
NSC 614887 |
Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) |
0.00803384002766641 |
0.25153007 |
NSC 637411 |
Null |
0.00803384002766641 |
0.23792089 |